ArticleScientific reports2017

Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.

Majid Momeny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.